Clinical Trial Update: A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

View source ↗

Summary

The study evaluating venetoclax tablets in adults with acute myeloid leukemia ineligible for standard induction therapy in the Russian Federation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venclexta (venetoclax) (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia (AML) | Status: COMPLETED